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ABSTRACT The expansion of the genetic repertoire of an organism by gene dupli-
cation or horizontal gene transfer (HGT) can aid adaptation. Streptomyces bacteria
are proliﬁc producers of bioactive specialized metabolites that have adaptive func-
tions in nature and have found extensive utility in human medicine. While the bio-
synthesis of these specialized metabolites is directed by dedicated biosynthetic gene
clusters, little attention has been focused on how these organisms have evolved ro-
bustness in their genomes to facilitate the metabolic plasticity required to provide
chemical precursors for biosynthesis during the complex metabolic transitions from
vegetative growth to specialized metabolite production and sporulation. Here, we
examine genetic redundancy in actinobacteria and show that specialized metabolite-
producing bacterial families exhibit gene family expansion in primary metabolism.
Focusing on a gene duplication event, we show that the two pyruvate kinases in the
genome of Streptomyces coelicolor arose by an ancient duplication event and that
each has evolved altered enzymatic kinetics, with Pyk1 having a 20-fold-higher kcat
than Pyk2 (4,703 s1 compared to 215 s1, respectively), and yet both are constitu-
tively expressed. The pyruvate kinase mutants were also found to be compromised
in terms of ﬁtness compared to wild-type Streptomyces. These data suggest that ex-
panding gene families can help maintain cell functionality during metabolic pertur-
bation such as nutrient limitation and/or specialized metabolite production.
IMPORTANCE The rise of antimicrobial-resistant infections has prompted a resur-
gence in interest in understanding the production of specialized metabolites, such
as antibiotics, by Streptomyces. The presence of multiple genes encoding the same
enzymatic function is an aspect of Streptomyces biology that has received little at-
tention; however, understanding how the metabolic expansion inﬂuences these or-
ganisms can help enhance production of clinically useful molecules. Here, we show
that expanding the number of pyruvate kinases enables metabolic adaptation, in-
creases strain ﬁtness, and represents an excellent target for metabolic engineering of
industrial specialized metabolite-producing bacteria and the activation of cryptic
specialized metabolites.
KEYWORDS actinobacteria, primary metabolism, Streptomyces, antibiotics, evolution,
pyruvate kinase
A remarkable feature of specialized metabolite-producing actinobacterial genomesis the annotation of multiple genes that encode the same putative biochemical
function (1, 2). This expansion of gene families by gene duplication or horizontal gene
transfer (HGT) is thought to introduce robustness into biological systems, which in turn
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facilitates evolvability and adaptation (3–5). The expansion of gene families results in
relaxed selection following the gene duplication or HGT event, which allows the
accumulation of mutations which enable diversiﬁcation of function to occur (6). This
suggests that gene family expansion within genomes is a key driver of biological
innovation by facilitating adaptation (7). The production of extensive specialized me-
tabolites by certain actinobacterial lineages is thought to be a key adaptive response
to life in complex, highly competitive environments such as soil (8–10) and, as such,
may drive the expansion of primary metabolic capability, providing the metabolic
robustness that facilitates the evolution of novel biosynthetic functions.
Surprisingly, many central metabolic enzymes are nonessential for survival due to
genetic redundancy through the presence of isoenzymes or metabolic bypasses. The
redundancy allows cells to adapt to a variety of habitats and dynamic environmental
conditions through provision of metabolic plasticity (11). While this has been studied in
the unicellular enteric bacterium Escherichia coli and the yeast Saccharomyces cerevisiae
(12), little attention has been paid to organisms with an extensive specialized metab-
olism such as Streptomyces. Gene families of actinobacterial developmental genes have
been studied at the genetic level (7, 13, 14), but little attention has been paid to either
central or specialized metabolism (15) and how the supply of biosynthetic precursors
is maintained during the adaptive response under challenging environmental condi-
tions.
In actinobacteria, production of specialized metabolites is frequently growth phase
dependent and usually in response to nutrient starvation and during entry into the
sporulation phase of the life cycle (16). This creates a potential metabolic conﬂict for an
organism, where declining availability of metabolites may constrain certain cellular
processes in favor of others, such as reducing cellular pools of metabolites that are used
directly for specialized metabolite biosynthesis. Under these conditions, it is likely that
genetic redundancy can promote robustness and plasticity that helps to maintain
cellular function in the face of perturbation (17, 18), while allowing sporulation and
specialized metabolite production to occur.
Here, we systematically examine the genetic redundancy within the genomes of
specialized metabolite-producing actinobacteria to understand how genetic robust-
ness enables the evolution of extensive specialized metabolism. Moreover, a detailed
functional analysis of a redundant, duplicated pyruvate kinase (PK) gene pair from
Streptomyces coelicolor A3(2) indicates that biochemical diversiﬁcation at the enzyme
level facilitates the evolution of distinct physiological roles which enable functionality
during the metabolic reprogramming that is associated with physiological differentia-
tion and increased ﬁtness.
RESULTS
Gene expansion events are overrepresented in specialized metabolite-
producing actinobacteria. To determine if gene expansion events in central metab-
olism occur with greater frequency in specialized metabolite-producing organisms, a
database of 612 actinobacterial genomes spanning 80 genera was compiled (see
Table S1 at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1). All genomes were retrieved
from GenBank, reannotated with RAST (19) to ensure consistency of annotation across the
database, and then analyzed in a bespoke bioinformatics pipeline based on EvoMining (20,
21) (see Fig. S1 and Table S1 at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1). It was
hypothesized that, if precursor-supplying pathways are a contributing factor to the
adaptive response of specialized metabolite production, then the enzymatic nodes
contributing to precursor supply should be overrepresented in the database (Table 1;
also see Tables S1 and S2 at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1).
Expansion events were deﬁned as cases where the number of enzyme family
members per suborder had a value equal to or higher than the mean number of
members per phylum plus its standard deviation. The glycolytic pathway showed the
highest number of gene expansion events, in the Streptomycineae and Catenulispori-
neae, with 23.3% and 25.0% more genes encoding glycolytic function than was average
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for that pathway in the phylum Actinobacteria, respectively (Table 1). Pseudonocar-
dineae showed the highest number of gene expansions in gluconeogenesis (25%
higher than the mean phylum value) and in the tricarboxylic acid (TCA) cycle (28.3%
higher than the mean phylum value). This was also true for many amino acid biosyn-
thetic pathways. Where the main precursor is derived from 2-oxoglutarate (Glu, Gln,
Pro, and Arg), expansion was 20.1% more than the mean suborder value, and expansion
was 31.3% more with pyruvate-derived amino acids (Ala, Ile, Leu, and Val), 20.7% more
with oxaloacetate-derived amino acids (Asp, Asn, Thr, Met, and Lys), 24% more with
3-phosphoglycerate (3PGA)-derived amino acids (Gly, Ser, and Cys), and 19.4% more
with erythrose-4-phosphate (E4P)/phosphoenolpyruvate (PEP)-derived amino acids
(Tyr, Phe, and Trp).
Focusing on the genus Streptomyces, which is renowned as being among the most
talented of genera in terms of specialized metabolite production, it was found that 14
enzymatic steps from central metabolism (glycolysis, TCA cycle, and amino acid me-
tabolism) represented gene expansion events, such that they are overrepresented in
this genus compared to the rest of the database. The following enzyme functions were
found to be overrepresented in the genus Streptomyces compared to the whole
actinobacterial phylum: phosphofructokinase (PFK), pyruvate kinase (PK), pyruvate
phosphate dikinase (PPDK), malic enzyme (ME), pyruvate dehydrogenase complex E1
(PDHC E1), chorismate mutase, acetylglutamate kinase, diaminopimelate decarboxyl-
ase, aspartate aminotransferase, aspartate-semialdehyde dehydrogenase, serine hy-
droxymethyltransferase, glutamine synthetase, argininosuccinate lyase, and methio-
nine synthetase (see Table S2 at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1).
Phylogenetic analysis of these expansions indicated that only two gene expansion
events are the result of duplication: pyruvate kinase and phosphofructokinase (pfkA2
and pfkA3; previously characterized by Borodina et al. [22]; a phylogenetic analysis of
pfk is provided in Fig. S4 at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1). The re-
maining expansion events in primary metabolism appear to have arisen through HGT.
To investigate how gene expansions through duplication in Actinobacteria are a
potential prerequisite for increasing robustness in specialized metabolism capability,
the duplicated pyruvate kinases from Streptomyces were studied further due to their
central role in carbon metabolism linking glycolysis, gluconeogenesis, and the TCA
cycle.
Pyruvate kinases in Streptomyces arose by gene duplication. PK catalyzes the
terminal step of glycolysis, converting one molecule of phosphoenolpyruvate to one
molecule of pyruvate using ADP as the phosphor acceptor, resulting in the production
TABLE 1 Percentage of primary metabolic pathway gene expansion per suborder and pathway of central carbon metabolisma
Order/suborder
No. of
genera
No. of
species
% expansion per pathway (no. of enzymes in minimum pathway):
GLY (10) GNG (5) PPP (7) TCA (17)
AA derived from:
2OG (13) PYR (10) OAA (18) 3PGA (7) R5P (10) E4P/PEP (18)
Streptomycineae 3 303 23.3 8.3 4.8 8.3 11.9 11.1 10.5 16.7 NE 14.0
Catenulisporineae 2 3 25.0 12.5 42.9 25.0 21.4 16.7 13.2 25.0 10.0 15.8
Streptosporangineae 9 28 6.7 11.1 3.2 13.2 10.3 17.3 11.7 11.1 3.3 12.3
Frankineae 3 11 6.7 NE 23.8 NE 11.9 NE 8.8 11.1 10.0 8.8
Pseudonocardineae 16 57 10.6 25.0 17.0 28.3 20.1 31.3 20.7 24.0 17.5 19.4
Corynebacterineae 8 62 7.5 9.4 5.4 10.2 8.7 8.3 6.6 6.3 7.5 5.3
Micromonosporineae 9 19 20.0 13.9 15.9 16.7 14.3 18.5 21.1 13.0 23.3 13.5
Glycomycineae 1 3 NE 0.0 14.3 NE 7.1 NE 5.3 NE NE NE
Micrococcineae 17 74 6.5 5.9 5.0 5.5 4.6 2.6 8.4 6.9 3.5 4.0
Bifidobacteriales* 1 3 NE NE 14.3 NE 0.0 11.1 21.1 NE 10.0 NE
Actinomycineae 2 26 NE NE 7.1 NE 0.0 NE NE NE NE 5.3
Kineosporiineae 1 1 20.0 NE 28.6 NE 14.3 NE 21.1 NE 20.0 5.3
Propionibacterineae 8 24 13.8 12.5 7.1 9.4 7.1 18.1 11.8 12.5 7.5 4.6
aThe highest percentage of gene expansion for each pathway is highlighted in bold. Abbreviations: GLY, glycolysis; GNG, gluconeogenesis; PPP, pentose phosphate
pathway; TCA, tricarboxylic acid cycle; AA, amino acids; 2OG, 2-oxoglutarate; PYR, pyruvate; OAA, oxaloacetate; 3PGA, 3-phosphoglycerate; R5P, ribose-5-phosphate;
E4P, erythrose-4-phosphate; PEP phosphoenolpyruvate; NE, no expansion. *, order Bifidobacteriales.
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of ATP. PK therefore plays a key role in linking glycolysis and the citric acid cycle.
Moreover, it results in the formation of a direct precursor of acetyl coenzyme A
(acetyl-CoA), which feeds directly into polyketide specialized metabolites. A high-
resolution species-level phylogeny of the Actinobacteria was constructed using the 
subunit of RNA polymerase (RpoB [23, 24]), which allowed the segregation of the
phylum into three distinct phylogenetic branches: one composed of Streptomycineae
and Catenulisporineae; a second including Propionibacterineae, Actinomycineae, Bifido-
bacteriales, and Micrococcineae; and the third one with Micromonosporineae, Glycomy-
cineae, Corynebacterineae, Pseudonocardineae, Frankineae, and Streptosporangineae
(Fig. 1A).
A second phylogeny of the annotated PKs of the Actinobacteria was constructed. It
indicated that there is a high level of congruence with the RpoB phylogeny, as
expected for a central metabolic enzyme (Fig. 1B). However, a bifurcating topology
within the Streptomycetaceae family was found, which contained the two genes en-
coding the putative PKs. This topology indicates that a gene duplication event oc-
curred, giving rise to two PKs within this group. Analysis of 286 Streptomyces species
showed that 281 species have duplicate copies of PK, three species possess a single
copy (Streptomyces somaliensis, Streptomyces sp. strain NRRL F5135, and Streptomy-
ces scabrisporus), two species have three copies (Streptomyces olindensis and Strepto-
myces sp. strain AcH505), and a single species has four copies (Streptomyces resistomy-
cificus). Interestingly, Streptomyces sp. AcH505 and S. resistomycificus had one copy of
pyk in each main branch of the PK tree and additional copies were found to be
phylogenetically distant (orange branches in Fig. 1B), suggesting that these copies were
acquired through horizontal gene transfer (HGT). Overall, 92% (302 of 327) of actino-
bacterial genomes outside the genus Streptomyces encoded a single PK, reinforcing the
uniqueness of the duplication in this genus (Fig. 1B).
To determine if the duplicate PKs annotated in the Streptomyces genome have
pyruvate kinase activity, we used the two PKs from the model streptomycete S. coeli-
color A3(2) in genetic complementation tests of PK mutants of Escherichia coli. E. coli
also has two PKs: a primary enzyme encoded by pykF, which is a type I enzyme,
regulated allosterically by fructose-1,6-biphosphate (FBP), and a distinct secondary type
II PK (pykA), regulated allosterically by AMP (25). In Streptomyces, both PKs (Pyk1 and
Pyk2) are type II enzymes regulated by AMP. To test for functional complementation,
E. coli mutants (pykA, pykF, and a pykApykF double mutant [see Table S4 at
https://doi.org/10.6084/m9.ﬁgshare.5772963.v1]) were tested, along with the isogenic
parental strain (E. coli BW25113) for their ability to grow under a range of physiological
conditions (Fig. 1C). In LB (for which PK is dispensable for growth) and M9 plus acetate
as the sole carbon source (where PK is also dispensable for growth), little difference was
observed in the speciﬁc growth rate (hour1) of the strains. When the strains were
grown in M9 plus glucose as the sole carbon source (where PK is essential for growth),
the E. coli pykA pykF double mutant was unable to grow but could be genetically
complemented with either pyk1 (SCO2014) or pyk2 (SCO5423) from S. coelicolor. The
individual E. coli ΔpykA and ΔpykF mutants had reduced speciﬁc growth rates (around
50% of the rate of the isogenic parent strain) in M9 plus glucose. Genetic complemen-
tation with pyk1 or pyk2 from S. coelicolor was able to restore growth of an E. coli pykF
mutant as expected. The E. coli pykA mutant could be complemented only with pyk2
from S. coelicolor, suggesting a much more limited physiological role for pykA in E. coli
(Fig. 1C). Remarkably, pyk2 is the closest BLAST homologue of pykA in the S. coelicolor
genome (43% identity). These data conﬁrm that both pyk1 and pyk2 from S. coelicolor
have retained PK activity following the duplication event but that each has diverged
and evolved different physiological roles.
Given that the PKs in S. coelicolor have diverged following duplication, we assessed
the level of selection imposed on the PKs of Streptomyces by calculating the ratio of
nonsynonymous changes (dN) to synonymous changes (dS). Twenty PK sequences from
10 Streptomyces genomes were chosen to calculate the dN, dS, and dN/dS values. The
dN/dS ratio for pairs of pyk sequences for each of the genomes yielded dN/dS ratios
Schniete et al. ®
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FIG 1 Phylogenetic analysis of RpoB and PK across 80 different actinobacterial genera grouped and color coded by order/suborder. (A)
Phylogenetic tree based on RpoB protein sequences. (B) Phylogenetic tree based on pyruvate kinase protein sequences. Gray circles
indicate the Streptomycineae. (C) Speciﬁc growth rate of E. coli pyruvate kinase mutants (ΔpykA, ΔpykF, and ΔpykA ΔpykF) and the mutants
complemented with either pyk1 or pyk2 from S. coelicolor on M9 medium with glucose as carbon source. *, P value  0.05; **, P value 
0.01; ***, P value  0.001.
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ranging from 0.407 to 0.500, suggesting that PKs in Streptomyces are under strong
purifying selection (see Table S3 at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1).
Such high levels of purifying selection indicate that the duplication event in Strepto-
myces is likely to be ancient and is consistent with the PK tree topology (Fig. 1B).
The two pyruvate kinases in Streptomyces have distinct physiological roles. To
determine the roles played by the PKs in growth, development, and antibiotic produc-
tion, a series of mutant S. coelicolor strains was constructed and genetically comple-
mented (see Table S4, Table S5, and Fig. S2 at https://doi.org/10.6084/m9.ﬁgshare
.5772963.v1). Deletion mutants and transposon insertion mutants showed similar
phenotypes (see Fig. S2 at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1), and all
subsequent work was carried out with transposon insertion mutants. Growth on
nutrient agar showed no differences between the strains, except when an additional
copy of pyk1 was present in the wild type (WT) in trans, resulting in overproduction of
actinorhodin (ACT) in rich medium and undecylprodigiosin (RED) in minimal medium
(Fig. 2A). During culture on solid minimal medium with 1% glucose as carbon source,
the strains showed no growth defects compared to the wild type (Fig. 2A). Interestingly,
the pyk1::Tn5062 mutant showed an increase in specialized metabolite production
(Fig. 2A, C, and D). The pyk2::Tn5062 strain was marginally affected in growth and
showed no overexpression of specialized metabolites (Fig. 2A). No changes in growth
rate were observed in rich medium (YEME medium) for the WT, mutants, or comple-
mented strains (Fig. 2B). However, growth of the strains in this medium showed an
increase in production of the polyketide coelimycin (26) and RED in the pyk1::Tn5062
mutant (Fig. 2C), whereas a pyk2::Tn5062 mutant showed reduced antibiotic yields
(Fig. 2C and D). These data suggest that each PK isoenzyme plays a distinct physio-
logical role in growth of Streptomyces and that perturbation of central metabolism by
their deletion or addition affects specialized metabolite biosynthesis. This would sug-
gest that the PKs either are regulated differently at key stages of the Streptomyces life
cycle at the level of transcription or are regulated at the posttranscriptional/transla-
tional level.
To test this hypothesis, we used semiquantitative reverse transcription-PCR (RT-PCR)
to examine the expression of the PKs from S. coelicolor throughout growth, relative to
the multiplexed vegetative sigma factor encoded by hrdB. We found that both genes
were constitutively expressed throughout growth (vegetative hyphae and aerial hy-
phae and during sporulation) relative to hrdB (Fig. 3A). To further characterize tran-
scription, we used quantitative real time PCR (qRT-PCR) at two time points during log
and stationary phase during either glycolytic growth (glucose as sole carbon source) or
anaplerotic/gluconeogenic growth (Tween as sole carbon source [27]) to analyze the
expression levels of pyk1, pyk2, and hrdB. Normalizing expression to hrdB, there was an
expected decrease in pyk1 expression on Tween compared to glucose during the log
and stationary phases of growth (3-fold and 8-fold, respectively [Fig. 3A and B]).
Comparison of pyk1 and pyk2 during the logarithmic growth phase indicated that pyk2
had a 1.5-fold-lower level of expression when grown on Tween as the sole carbon
source than it did in stationary phase, with all other conditions showing no signiﬁcant
changes in expression between pyk1 and pyk2 (Fig. 3B, i), suggesting that activity of PKs
in Streptomyces is likely to be controlled at the posttranslational level. Expression of
pyk2 also showed a decrease in expression on Tween compared to that on glucose
during both phases, but the change was not signiﬁcant (Fig. 3B, ii).
Pyk1 and Pyk2 in Streptomyces have key substrate affinity differences and
specific effector molecules. To understand the biochemical control of the two PKs of
S. coelicolor, we puriﬁed each enzyme and studied its biochemical characteristics. Both
Pyk1 and Pyk2 were activated by the effector molecule AMP, and they both showed
Michaelis-Menten-type kinetics for the substrate ADP. For Pyk1, S0.5 (substrate concen-
tration at half Vmax) was 3-fold lower in the presence of 1 mM AMP (0.6 mM down to
0.2 mM [Table 2]), while Vmax also increased 3.5-fold (from 21 U/mg to 73.3 U/mg). Pyk2
showed a 5-fold increase of Vmax in the presence of 1 mM AMP (from 1.2 U/mg to
Schniete et al. ®
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6.7 U/mg). S0.5 decreased 3-fold (from 0.3 mM to 0.1 mM [Table 2] [see also Fig. S2 at
https://doi.org/10.6084/m9.ﬁgshare.5772963.v1]). There were profound differences in
the PEP kinetics for the two PKs, with both isoenzymes demonstrating Hill-type
cooperative binding kinetics with AMP. In the presence of 1 mM AMP, Vmax of Pyk1
FIG 2 Phenotypic characterization of pyruvate kinase mutants. (A) Wild-type and pyk1 and pyk2 transposon mutants of S. coelicolor grown
on nutrient agar and minimal medium (MM) with glucose, with strains complemented with either pyk1 or pyk2 in trans and WT strains with
additional copies of pyk1 or pyk2. (B) Growth curve of S. coelicolor WT, pyruvate kinase mutants, and complemented strains in liquid YEME
medium. (C and D) Coelimycin production yield (absorption unit [AU] per milligram of biomass) (C) and undecylprodigiosin (RED) yield
during growth in YEME medium (D). Symbols: black circles, WT; blue squares, pyk1 pyruvate kinase mutant; red inverted triangles, pyk2
pyruvate kinase mutant; purple triangles, pyk1-complemented strain; pink diamonds, pyk2-complemented strain.
Metabolic Robustness in Streptomyces ®
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increased 5-fold (14.1 U/mg to 65.45 U/mg), S0.5 decreased more than 3-fold (3.5 to
1.1 mM), and the Hill coefﬁcient was approximately halved (from 3.7 to 1.8). For Pyk2
in the presence of 1 mM AMP, Vmax was 9.1 U/mg compared to 0.5 U/mg without AMP,
with S0.5 increasing from 1.3 mM to 8.6 mM. Under these conditions, the Hill coefﬁcient
increased from 1.5 to 7.1 (Table 2). Further analysis demonstrated that Pyk1 has a much
higher afﬁnity for AMP (S0.5  0.01 mM) than does Pyk2 (S0.5  3.8 mM), with a
concomitant increase in Vmax (8.2 U/mg for Pyk1 compared to 1 U/mg for Pyk2 [see
FIG 3 (A) Semiquantitative RT-PCR of expression of pyk1, pyk2, and hrdB throughout the life cycle of Streptomyces
coelicolor. (B) Fold change expression of pyk1 and pyk2 normalized to hrdB expression from three biological
replicates measuring expression levels by qPCR on growth in minimal medium with either glucose or Tween as
carbon source during log or stationary phase comparing expression in stationary phase versus log phase (i) and
Tween versus glucose (ii). *, P value  0.05. (C) Fitness of pyk1 (dark blue circles) and pyk2 (red squares) mutants
compared to WT and each other (relative to pyk1) in rich medium (green triangles) and minimal medium with
glucose (orange inverted triangles) as sole carbon source. Error bars represent the standard deviation from three
biological replicates, with the mean indicated. The line (at a relative ﬁtness of 1.0) indicates the ﬁtness of a strain
when competed against itself.
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Fig. S3C at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1]). The turnover rate con-
stant (kcat) for Pyk1 was 20-fold greater (4,703 s
1) than that for Pyk2 (215 s1
[Table 2]). Interestingly, Pyk1 was also shown to be highly stimulated by ribose-5-
phosphate (see Fig. S3 at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1). Intriguingly
it is known that ﬂux through the pentose phosphate pathway (PPP) increases during
entry into stationary phase in streptomycetes (28), suggesting that Pyk1 activity is
stimulated during periods of starvation and during antibiotic production to rebalance
reduced glycolytic ﬂux and entry of substrates into the TCA cycle.
Pyruvate kinase mutants are less fit than wild-type S. coelicolor. Given that the
PK gene duplication has been retained in streptomycetes, it would suggest that there
is a ﬁtness advantage conferred by having more than one copy of PK. To test this
hypothesis, we competed marked WT (with integrated empty pIJ6902, thiostrepton
resistant) with pyk1::Tn5062 (apramycin-resistant) and pyk2::Tn5066 (hygromycin-
resistant) strains to assess the relative ﬁtness of each strain. In rich medium, where PK
should be dispensable for growth, there is no signiﬁcant difference between WT and PK
mutants in terms of ﬁtness (Fig. 3C). When the ﬁtness of the PK mutants was assessed
in minimal medium with glucose as the sole carbon source, where PK should be
required for growth, strains with a single PK have signiﬁcantly reduced ﬁtness com-
pared to WT (Fig. 3C) (pyk1::Tn5062, P  0.05; pyk2::Tn5066, P  0.01). The distinct
physiological roles of Pyk1 and Pyk2 in Streptomyces suggest that the relative ﬁtness of
each mutant would differ when competed against each other. In rich medium, the
pyk1::Tn5062 strain exhibits increased relative ﬁtness compared to the pyk2::Tn5066
strain (Fig. 3C) (P  0.05); however, in minimal medium with glucose as the sole carbon
source, the pyk1::Tn5062 strain is less ﬁt than the pyk2::Tn5066 strain (Fig. 3C) (P  0.01).
These data demonstrate that possession of two copies of PK confers increased relative
ﬁtness to strains of Streptomyces under different physiological conditions.
DISCUSSION
Metabolic robustness is a key biological adaptation to coping with environmental
perturbation that enables an organism to persist in an environment (17). The ability of
an organism to adapt to dynamic and competitive environments requires minimization
of the effects of metabolic perturbations, which can be achieved through gene family
expansion following either gene duplication or HGT. During nutrient stress, intracellular
concentrations of key metabolic intermediates can fall, which, when coupled with
increasing demand during specialized metabolite biosynthesis, may produce metabolic
conﬂict in cells. PK occupies a key position in carbon metabolism, bridging glycolysis to
the TCA cycle, and plays a central role in the generation of ATP and precursors for the
synthesis of specialized metabolite precursors (acetyl-CoA, amino acids, organic acids,
TABLE 2 Kinetic characteristics of Pyk1 and Pyk2 for the substrates ADP and PEP and the
activator AMP
Substrate or activator Parameter
No AMP 1 mM AMP
Pyk1 Pyk2 Pyk1 Pyk2
5 mM PEP with ADP Vmax (U/mg) 21.0 1.2 73.3 6.7
S0.5 (mM) 0.6 0.3 0.2 0.1
kcat (s
1) 941 39 4,703 215
kcat/Km (mM
1 s1) 1,594 145 31,359 2,388
1.5 mM ADP with PEP Vmax (U/mg) 14.1 0.5 65.5 9.1
S0.5 (mM) 3.5 1.3 1.1 8.6
Hill coefﬁcient 3.7 1.5 1.8 7.1
kcat (s
1) 350 18 4,200 336
kcat/S0.5 (mM
1 s1) 100 14 4,000 39
AMP Vmax (U/mg) 8.2 1
S0.5 (mM) 0.01 3.8
kcat (s
1) 423.7 42.0
kcat/S0.5 (mM
1 s1) 42,373 11
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etc. [27]). At key branch points in metabolism, such as here, the levels of metabolites
are tightly controlled (29), and in E. coli, the ﬂux between PEP and pyruvate is stably
maintained by two phylogenetically distinct PKs (25, 30). In the streptomycetes, a
duplication event has led to the evolution of altered substrate afﬁnity and enzyme
efﬁciency in the two duplicate copies which contribute to metabolic robustness
enabling cellular processes to occur during times of perturbation, such as at the entry
into stationary phase and specialized metabolite production.
Enzyme family expansion in central metabolism is widespread in the Actinobacteria,
in particular with those genera that are extensive producers of specialized metabolites
(21) (see Table S1 at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1), with the Strepto-
mycineae showing extensive enzyme family expansion in glycolysis. Within glycolysis,
only two enzyme families show duplication as a route to expansion. Borodina et al. (22)
showed that PfkA2 was the primary phosphofructokinase in S. coelicolor but did not
study the wider role of duplication or a detailed kinetic comparison of the expansion
event. The duplication of pyruvate kinase is ancient and has permitted subsequent
divergence of the gene pair to evolve distinct physiological roles, where Pyk2 appears
to function as a housekeeping PK, with a higher afﬁnity for PEP (when AMP is low), and
Pyk1 exhibits strong activation as AMP concentrations rise. An increased AMP concen-
tration is a well-established starvation signal in bacteria (31) and may serve to increase
ﬂux through the terminal end of glycolysis during starvation to facilitate precursor
supply for specialized metabolites. Moreover, the PPP intermediate ribose-5-phosphate
stimulates Pyk1 activity, providing a physiological link between the PPP and the
associated generation of NADPH, which has established links to synthesis of specialized
metabolites, including those overproduced by strains engineered in this work (28).
Disruption of pyk1 in S. coelicolor leads to increased levels of coelimycin and undecyl-
prodigiosin when grown in rich medium (such as in industrial situations) but no
signiﬁcant increase in the yield of the polyketide antibiotic actinorhodin, which may
reﬂect the ranges of different metabolic control points affecting biosynthesis of chem-
ically similar specialized metabolites. The regulation of this node is known to be
controlled by at least one global regulator, ScbR2, which is encoded in the coelimycin
(cpk) biosynthetic gene cluster (BGC). ScbR2 expressed in mid-log phase has been
shown to bind to pyk2 and reduce its expression. ScbR2 is also a regulator of ACT and
RED biosynthesis in addition to the angucyclines (32). Interestingly, coelimycin was
originally considered to be a cryptic BGC and the disruption of PK activity results in
increased production of this molecule, suggesting that strategies that affect precursor
supply may activate the plethora of cryptic biosynthetic pathways in Actinobacteria and
may provide a useful strategy for studying these molecules.
Our data demonstrate that the duplication of pyruvate kinase promotes metabolic
robustness through altered kinetic parameters which increase the relative ﬁtness of
strains and inﬂuence the production of specialized metabolites. Understanding the
evolution of central metabolism in conjunction with specialized metabolism can con-
tribute to our fundamental understanding of the ability of Actinobacteria to produce a
plethora of useful molecules and can help inform on novel approaches to metabolic
engineering and genome mining (21).
MATERIALS AND METHODS
Database generation and bioinformatics analysis. The NCBI database (https://www.ncbi.nlm.nih
.gov/genbank/wgs) was the source of actinobacterial genomes having a minimum coverage of 25 and
less than 30 contigs per mega-base pair. To ensure a wide range of phylogeny, a selection of 612 species
from 80 genera were included. Each genome was reannotated using RAST (19), and the annotation ﬁles
were used to determine the frequency of each functional annotation. The mean number of occurrences
of each functional role was calculated per genus, and examples which had a value equal to or higher than
the mean plus its standard deviation were deﬁned as a “gene expansion event.” Each candidate protein
sequence was extracted from the actinobacterial genome database to form a BLASTP analysis working
database. The sequences were then aligned with MUSCLE v3.8.31 (33), and alignments were scrutinized
using Jalview v2.10.1 to ensure that at least 25% coverage with the query was achieved; if not, sequences
and expansions were discarded from the working database. Phylogenetic analysis of the alignments was
conducted using MrBayes (34) v3.2.3 with trees visualized in FigTree v1.4.2 (http://tree.bio.ed.ac.uk/
software/ﬁgtree/). Sequences were obtained from the NCBI gene database and aligned with ClustalW
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algorithm in MEGA v6.06 (35), and the synonymous (dS) and nonsynonymous (dN) changes were
determined using the distance model function with the Nei-Gojobori method (36) with the Jukes-Cantor
algorithm (37) bootstrap.
Growth and mutant construction in Streptomyces. A full list of strains, plasmids and oligonucle-
otides used in this study is provided in Tables S4, S5, and S6 at https://doi.org/10.6084/m9.ﬁgshare
.5772963.v1. Routine growth, spore generation, and conjugation of Streptomyces strains were carried out
according to the work of Kieser et al. (38). Antibiotic titers were determined according to the work of
Gomez-Escribano et al. (26) for coelimycin and the work of Kieser et al. (38) for RED and ACT. S. coelicolor
gene knockout mutants (pyk1 and pyk2) were constructed using PCR-targeted gene replacement with
an apramycin resistance cassette [acc(3)IV] using the Redirect system (39) and the primers reported in
Table S6 at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1. S. coelicolor transposon insertion mutants
(pyk1::Tn5062 and pyk2::Tn5062) were constructed using Tn5062 mutagenized cosmids as described in
the work of Fernández-Martínez et al. (40). Each cosmid was ﬁrst veriﬁed by restriction analysis before
being conjugated into Streptomyces. All strains were veriﬁed by PCR and sequencing of the respective
products. Growth curves were performed at a 400-ml scale in minimal medium (28) with either 1%
glucose or Tween 80 as the carbon source in 2-liter ﬂasks containing a metal spring at 30°C and 250 rpm.
Interspecies complementation. E. coli single mutants were from the Keio collection of E. coli
BW25113 (41), and the double mutant was constructed using  Red recombination of pykF according to
the work of Datsenko and Wanner (42). Complementation studies used the Streptomyces pyk1 and pyk2
genes cloned into pET100_TOPO (Invitrogen).
E. coli growth curves were carried out in 250-ml ﬂasks with a working volume of 50 ml of either LB
or M9 medium with 1% (wt/vol) glucose or 0.4% (wt/vol) sodium acetate as carbon source. Flasks were
inoculated from an overnight culture (1% [vol/vol]) including the appropriate antibiotics and 1 mM
isopropyl--D-thiogalactopyranoside (IPTG) to induce expression of the PKs. Growth was followed as
optical density at 600 nm (OD600) at 37°C with shaking at 250 rpm. The speciﬁc growth rate was
determined from the semilogarithmic plot of biomass concentration.
Protein overexpression and purification. The coding sequence of pyk1 was codon optimized for
E. coli and ampliﬁed from the vector pEX-K4 using the primers in Table S6 at https://doi.org/10.6084/
m9.ﬁgshare.5772963.v1. The native version of pyk2 was used to amplify the coding sequence using the
primers in Table S6 at https://doi.org/10.6084/m9.ﬁgshare.5772963.v1. Both coding sequences were
cloned into the pET100_TOPO vector (Invitrogen) according to the manufacturer’s instructions. Overex-
pression of pyk1 was in E. coli Origami B on LB with 1% (wt/vol) glucose at 30°C until an OD600 of 0.4 was
reached, and the expression was induced with 0.05 mM IPTG at 18°C overnight. Pyk2 overexpression was
in E. coli Rosetta using autoinduction medium [components per liter: 10 g tryptone, 5 g yeast extract,
3.3 g (NH4)2SO4, 6.8 g KH2PO4, 7.1 g Na2HPO4, 0.5 g glucose, 2.0 g -lactose, 0.15 g MgSO4]; cells were
grown at 37°C for 2 h and then reduced to 18°C for overnight cultivation. Cells were disrupted by
sonication. Pyk1 and Pyk2 were puriﬁed by nickel afﬁnity chromatography using HisTrap FF crude (GE
Healthcare) with binding buffer (100 mM KH2PO4 pH 7.2, 10% [vol/vol] glycerol, 100 mM NaCl, 20 mM
imidazole). Tagged proteins were eluted with increasing imidazole concentrations (elution buffer:
100 mM KH2PO4 [pH 7.2], 10% [vol/vol] glycerol, 100 mM NaCl, 1 M imidazole). Fractions (1 ml) were
collected, and the highest concentrations of protein were pooled.
Kinetic characteristics of each pyruvate kinase were determined using puriﬁed protein samples
according to the method of Bergmeyer et al. (43). Assays to determine the enzyme kinetics for each PK
under each condition were carried out in triplicate, and results were analyzed using GraphPad Prism
using the Michaelis-Menten or Hill equation where appropriate.
RNA extraction, semiquantitative RT-PCR, and qPCR analysis. Biomass of S. coelicolor came from
liquid cultures, and semiquantitative RT-PCR was carried out according to the method of Clark and
Hoskisson (7). Total RNA was used as the template for cDNA synthesis using a qPCRBio cDNA synthesis
kit (PCR Biosystems). All cDNA samples were diluted to a concentration of 10 ng/l with each quanti-
tative PCR (qPCR) mixture containing 10 ng of cDNA (1 l) and were then mixed with 10 l MasterMix
(2 qPCRBio SyGreen mix Lo-ROX kit from PCR Biosystems) and 2.5 l of each primer to a ﬁnal reaction
volume of 20 l using the Corbett Research 6000 analyzer (Qiagen).
Fitness experiments. Competitive ﬁtness of PK mutants versus WT was estimated based on the work
of Lenski et al. (44). Brieﬂy, spores of each strain were separately pregerminated in 2 YT medium (38)
for 7 h at 30°C and washed twice in the culture medium to be used in the ﬁtness experiment. Germling
OD600 was determined, and a 10-ml culture was inoculated with approximately 1  10
5 CFU of each
strain. Initial and ﬁnal strain densities (after 68 h of growth) were determined by plating on nutrient agar
with the appropriate selection. The net growth rate of each competitor was calculated from the data, and
the relative ﬁtness of a strain is expressed as the ratio of its growth rate to that of its competitor. Assays
were performed in triplicate.
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